NCT05276973
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05276973
Title Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCSF Medical Center-Mission Bay San Francisco California 94158 United States Details
Augusta University Medical Center Augusta Georgia 30912 United States Details
Cleveland Clinic Foundation Cleveland Ohio 44195 United States Details
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
Women and Infants Hospital Providence Rhode Island 02905 United States Details
Virginia Commonwealth University/Massey Cancer Center Richmond Virginia 23298 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field